How high is your risk of dementia? It may depend on where you live

How high is your risk of dementia? It might depend on where you live, according to a new study of U.S. veterans.
A team at U.C. San Francisco said Monday that it had identified the regions where the chronic brain disorder occurs most often. Using the Mid-Atlantic region as the baseline for comparison, where dementia incidence rates were the lowest, they found that dementia was 25 percent higher in the Southeast. That included Kentucky, Tennessee, Alabama, and Mississippi. Whereas, the Northwest and Rocky Mountain regions were both 23 percent higher.
Other regions included in the study – one of the largest and most comprehensive of its kind – were the South and Southwest, which were 18 and 13 percent higher, respectively. California was included in the Southwest.
The Northeast incidence rates were still higher than the Mid-Atlantic, but just by 7 percent.
'The study underscores the need to understand regional differences in dementia and the importance of region-specific prevention and intervention efforts,' UCSF Director of the Center for Population Brain Health Dr. Kristine Yaffe said in a statement.
Yaffe was the senior author of the study, which was published in the journal JAMA Neurology.
The study included the health records from more than 1.2 million veterans, noting that veterans have a higher prevalence of risk factors such as traumatic brain injuries, depression, and post-traumatic stress.
The researchers found that the differences remained when they accounted for certain factors, including age, race, and cardiovascular disease.
They noted that access to medical care may be more difficult in rural areas, compared with urban areas. Previous research has found higher rates of dementia in rural communities.
Recently, other UCSF researchers found that proteins in spinal fluid may be the key to understanding why middle-aged people develop dementia.
The onset of dementia is known to be tied to depression, but different types have their own causes. Alzheimer's disease is the most common form, impacting some 6.7 million Americans. Cases are estimated to double by the year 2060. There is currently no cure.
The next step for these researchers is to investigate what the factors driving these differences are. They said they hoped that, by identifying areas with the highest incidence rates, resources can be better allocated and targeted interventions designed to mitigate the impact of dementia on vulnerable populations.
'Quality of education, early life conditions, and environmental exposures may be among those factors,' said first author Dr. Christina Dintica.

Try Our AI Features

Explore what Daily8 AI can do for you:

Learn with AIFact CheckingText to SpeechAI Summary

Related Articles

Times

2 hours ago

• Times

My brother died at 33 — what I wish I'd known

I remember seeing the troubling spark of recognition in the psychologist's eyes when I told her that my late brother, Charlie, had schizophrenia. We were sitting in her office going through a never-ending pile of forms as part of my seven-year-old son Eddie's autism-assessment process, including my family history. 'Did you know,' she asked, 'that autism used to be known as childhood schizophrenia?' I remember the grating rough texture of the chair I was sitting on prickling against the back of my legs and feeling the inside of my stomach flip. We lost my big brother, Charlie, in 2004 when he was 33 and he hadn't had a particularly happy life. He had been diagnosed with schizophrenia at the age of 18 after a period of psychosis — he had been hearing voices and became convinced that a group of people were out to get him.

The Independent

3 hours ago

• The Independent

Popular children's cough medicine recalled over potentially deadly bacterial infection risk

A popular cough medicine for children has been recalled over a risk of bacterial infection that can be deadly. Little Remedies Honey Cough Syrup was recalled Tuesday over the 'presence' of Bacillus cereus, a type of bacteria that can cause two types of foodborne illnesses, and because of 'loss of shelf-stability,' according to a notice from the medicine makers, Medtech Products Inc. The recall describes the symptoms associated with both foodborne illnesses. One can cause nausea, vomiting and stomach cramps starting one to six hours after consuming contaminated food. The second illness can cause stomach cramps and diarrhea starting 8 to 16 hours after exposure. 'Although healthy individuals may suffer only short-term illness, exposure to high levels of foodborne B. cereus can cause death,' the recall notice warned. No serious adverse effects have been reported as of the date of the recall. The recalled cough syrup was sold by retailers throughout the country and online from December 14, 2022, to June 4, 2025. Consumers with the recalled medicine are advised to stop using it immediately and contact their doctor if they experience any symptoms that may be related to the product. The company is also offering a refund of the product.

Reuters

3 hours ago

• Reuters

US judge blocks slashing of universities' federal funding from National Science Foundation

WASHINGTON, June 20 (Reuters) - A federal judge on Friday blocked the National Science Foundation from sharply cutting research funding provided to universities in the latest legal setback to efforts by U.S. President Donald Trump's administration to slash government support of research at major academic institutions.